Oral desensitization to 5-aminosalicylic acid medications

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 1, 1999, Pages 23-24

  Stelzle, Robert C ^a   Squire, Edward N ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; OLSALAZINE; SALAZOSULFAPYRIDINE;

ADOLESCENT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CROHN DISEASE; DESENSITIZATION; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ENTERITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RASH; ULCERATIVE COLITIS; URTICARIA;

EID: 0033498835     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63507-7     Document Type: Article

References (9)

1. Das KM, East wood MA, McManus JPA, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the reaction with drug metabolism and acetylator phenotype. N Engl J Med 1973;289:491-495.
2. Taffett SL, Das KM. Desensitization of patients with inflammatory bowel disease to sulfasalazine. Am J Med 1982;73:520-524.
3. Fardy JM, Lloyd DA, Reynolds RPE. Adverse effects with oral 5-aminosalicylic acid. J Clin Gastroenterol 1988; 10:635-637.
4. Bax DE, Amos RS. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Ann Rheum Dis 1986;45:139-140.
5. Koski JM. Desensitization to sulphasalazine in patients with arthritis. Clin Exp Rheumatol 1993;11: 169-170.
6. Purdy BH, Philips DM, Summers RW. Desensitization for sulfasalazine skin rash. Ann Intern Med 1984;100: 512-514.
7. Holdsworth CD. Sulfasalazine desensitisation. Br Med J 1981;282:110.
8. Tolia V. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. Am J Gastroenterol 1992;87: 1029-1032.
9. Smart BA, Adams CA, Lewis ST, Altman LC. Mesalamine desensitization for a patient with ulcerative colitis. J Allergy Clin Immunol 1998;101:8141.